Get the Stockscreener App
8.60
1.18%
0.10
After Hours:
8.72
0.12
+1.40%
Xencor Inc stock is traded at $8.60, with a volume of 791.75K.
It is up +1.18% in the last 24 hours and up +10.97% over the past month.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
See More
Previous Close:
$8.50
Open:
$8.51
24h Volume:
791.75K
Relative Volume:
1.11
Market Cap:
$613.38M
Revenue:
$133.62M
Net Income/Loss:
$-177.37M
P/E Ratio:
-2.9758
EPS:
-2.89
Net Cash Flow:
$23.50M
1W Performance:
+0.58%
1M Performance:
+10.97%
6M Performance:
-34.50%
1Y Performance:
-58.69%
1-Day Range:
$8.26
$8.70
1-Week Range:
$8.19
$8.73
52-Week Range:
$6.92
$27.24
Xencor Inc Stock (XNCR) Company Profile
Name
Xencor Inc
Sector
Industry
Phone
626-305-5900
Address
465 N. HALSTEAD ST., PASADENA, CA
Compare XNCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
8.60 | 596.26M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-21-25 | Initiated | William Blair | Outperform |
| Dec-12-24 | Initiated | Wells Fargo | Overweight |
| Dec-02-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-16-24 | Reiterated | BTIG Research | Buy |
| Feb-28-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-19-23 | Initiated | BofA Securities | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Oct-13-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Jul-06-22 | Resumed | Canaccord Genuity | Buy |
| Feb-11-22 | Initiated | BMO Capital Markets | Outperform |
| Jan-21-22 | Initiated | SMBC Nikko | Outperform |
| Dec-15-21 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Feb-24-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-04-20 | Initiated | Barclays | Underweight |
| Feb-25-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-30-20 | Initiated | RBC Capital Mkts | Outperform |
| Nov-20-19 | Resumed | Guggenheim | Neutral |
| Aug-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-13-19 | Initiated | Mizuho | Buy |
| Apr-12-19 | Initiated | Guggenheim | Buy |
| Mar-27-19 | Initiated | Berenberg | Buy |
| Mar-15-19 | Initiated | Raymond James | Outperform |
| Sep-10-18 | Resumed | BTIG Research | Buy |
| Mar-28-18 | Resumed | Leerink Partners | Outperform |
| Mar-02-17 | Initiated | Instinet | Neutral |
| Mar-02-17 | Reiterated | Wedbush | Outperform |
| Oct-04-16 | Initiated | Piper Jaffray | Overweight |
| Dec-22-15 | Initiated | Canaccord Genuity | Buy |
| Aug-05-15 | Reiterated | MLV & Co | Buy |
| Feb-12-15 | Reiterated | Oppenheimer | Outperform |
| Jan-28-15 | Reiterated | MLV & Co | Buy |
| Jul-11-14 | Initiated | Oppenheimer | Outperform |
View All
Xencor Inc Stock (XNCR) Latest News
Cubist Systematic Strategies LLC Invests $1.66 Million in Xencor, Inc. $XNCR - MarketBeat
RBC Cuts Xencor (XNCR) Price Target but Keeps Outperform Rating - MSN
Trexquant Investment LP Has $1.42 Million Position in Xencor, Inc. $XNCR - MarketBeat
Jacobs Levy Equity Management Inc. Acquires 384,509 Shares of Xencor, Inc. $XNCR - MarketBeat
Automated trading signals detected on Xencor Inc.Quarterly Earnings Summary & Short-Term High Return Strategies - Newser
Real time social sentiment graph for Xencor Inc.Portfolio Value Summary & Consistent Income Trade Recommendations - Newser
Xencor Inc. stock outlook for YEARWeekly Trade Review & Community Consensus Stock Picks - Newser
BofA Securities Downgrades Xencor(XNCR.US) to Hold Rating, Cuts Target Price to $12 - 富途牛牛
AI Indicators Detect Buy Opportunity in Xencor Inc.July 2025 Action & High Return Trade Opportunity Guides - beatles.ru
Xencor (NASDAQ:XNCR) Downgraded to Neutral Rating by Bank of America - MarketBeat
Top 10 Stocks Under $10 That Could Triple - Insider Monkey
Xencor (NASDAQ:XNCR) Given "Outperform" Rating at Wedbush - MarketBeat
Xencor Inc. At Critical Juncture — Bounce or Breakdown2025 Analyst Calls & Free Real-Time Volume Trigger Notifications - beatles.ru
Xencor (NASDAQ:XNCR) Stock Price Up 6%Still a Buy? - MarketBeat
ADAR1 Capital Management LLC Boosts Stock Holdings in Xencor, Inc. $XNCR - MarketBeat
Xencor Inc. stock trend outlook and recovery pathMarket Risk Analysis & Growth Oriented Trade Recommendations - Newser
What earnings revisions data tells us about Xencor Inc.2025 Bull vs Bear & High Return Trade Opportunity Guides - Newser
Will Xencor Inc. stock recover after earnings2025 Volatility Report & AI Enhanced Market Trend Forecasts - خودرو بانک
Is Xencor Inc. stock good for income investorsJuly 2025 Trends & Technical Pattern Recognition Alerts - خودرو بانک
Rafferty Asset Management LLC Raises Position in Xencor, Inc. $XNCR - MarketBeat
News impact scoring models applied to Xencor Inc.Trade Signal Summary & Safe Entry Momentum Stock Tips - Newser
Using Ichimoku Cloud for Xencor Inc. technicalsNew Guidance & Free Accurate Trade Setup Notifications - Newser
Can Xencor Inc. benefit from deglobalization2025 EndofYear Setup & Fast Exit and Entry Trade Guides - خودرو بانک
Intraday pattern recognizer results for Xencor Inc.Earnings Risk Summary & Real-Time Price Movement Reports - Newser
Is it time to cut losses on Xencor Inc.Weekly Trading Summary & Weekly High Potential Stock Alerts - Newser
Trend analysis for Xencor Inc. this week2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - Newser
Full technical analysis of Xencor Inc. stock2025 Sector Review & Safe Entry Zone Tips - Newser
Jump Financial LLC Purchases Shares of 50,473 Xencor, Inc. $XNCR - MarketBeat
Does Xencor Inc. have declining or rising EPSJuly 2025 Sentiment & Safe Entry Trade Signal Reports - خودرو بانک
Using fundamentals and technicals on Xencor Inc.Market Trend Summary & Fast Momentum Stock Entry Tips - Newser
Xencor at Cantor Conference: Strategic Advances in Immunology - Investing.com
Xencor at Cantor Conference: Strategic Advances in Immunology By Investing.com - Investing.com Canada
Will Xencor Inc. announce a stock splitQuarterly Trade Report & Consistent Profit Trading Strategies - خودرو بانک
Is Xencor Inc. a candidate for recovery playWeekly Stock Recap & High Return Stock Watch Alerts - Newser
How to build a dashboard for Xencor Inc. stockForecast Cut & High Win Rate Trade Alerts - Newser
Real time scanner hits for Xencor Inc. explainedMarket Performance Report & Technical Pattern Recognition Alerts - Newser
Nuveen LLC Purchases Shares of 161,149 Xencor, Inc. $XNCR - MarketBeat
Evaluating Xencor Inc. with trendline analysisQuarterly Earnings Summary & Fast Gain Stock Trading Tips - Newser
Earnings visualization tools for Xencor Inc.Quarterly Market Review & Smart Allocation Stock Tips - Newser
Xencor at Wells Fargo Conference: Strategic Advances in Biotech By Investing.com - Investing.com Canada
Xencor at Wells Fargo Conference: Strategic Advances in Biotech - Investing.com
Xencor Shares Fall After BofA Securities Downgrade - MarketScreener
Erasca, Candle, Xencor drop as BofA downgrades on lack of near-term catalysts - Seeking Alpha
Sector Update: Health Care - MarketScreener
B of A Securities Downgrades Xencor to Neutral with $12 PT. - AInvest
BofA Securities Downgrades Xencor to Neutral From Buy - MarketScreener
Xencor Inc. stock trendline breakdownEarnings Growth Report & Stepwise Swing Trade Plans - Newser
Xencor Inc Stock (XNCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):